| [1] |
谷铣之,殷蔚伯,等.肿瘤放射治疗学.北京:北京医科大学中国协和医科大学联合出版社,1997:737-738.
|
| [2] |
罗素霞,马保根,陈小兵,等.血清肿瘤标志物联合检测在肺癌诊断中的价值.中华检验医学杂志,2005,28(12):1266.
|
| [3] |
Brandes AA, Ermani M, Basso U, et al. Temozolomide as a secondline systemic regimen in recurrent high-grade glioma:a phase II study. Ann Oncol, 2001, 12(2):255-257.
|
| [4] |
Shaw EG, Bourland D, Marshall MG. Cancer of the central nervous system//Khan FM, Potish RA. Treatment planning in radiation oncology. Pennsylvania:Lippincott Williams and Wilkins, 1998:491-544.
|
| [5] |
van Rijn J, Heimans JJ, van den Berg J, et al. Survival of human glionm cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys, 2000, 47(3):779-784.
|
| [6] |
Corsa P, Parisi S, Raguso A, et al. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Tumori, 2006, 92(4):299-305.
|
| [7] |
Stupp R, Mason WP, van den Bent M J, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005, 352(10):987-996.
|